Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 188

1.

Systematic review and meta-analysis of adverse cardiovascular events associated with proton pump inhibitors used alone or in combination with antiplatelet agents.

Farhat N, Fortin Y, Haddad N, Birkett N, Mattison DR, Momoli F, Wu Wen S, Krewski D.

Crit Rev Toxicol. 2019 Mar;49(3):215-261. doi: 10.1080/10408444.2019.1583167. Epub 2019 Jun 13.

PMID:
31192763
2.

Trends in concomitant clopidogrel and proton pump inhibitor treatment among ACS inpatients, 2000-2016.

Farhat N, Haddad N, Crispo J, Birkett N, McNair D, Momoli F, Wen SW, Mattison DR, Krewski D.

Eur J Clin Pharmacol. 2019 Feb;75(2):227-235. doi: 10.1007/s00228-018-2564-8. Epub 2018 Oct 15.

PMID:
30324301
3.

Comparative, cross-sectional study of the format, content and timing of medication safety letters issued in Canada, the USA and the UK.

Bjerre LM, Parlow S, de Launay D, Hogel M, Black CD, Mattison DR, Grimshaw JM, Watson MC.

BMJ Open. 2018 Oct 8;8(10):e020150. doi: 10.1136/bmjopen-2017-020150.

4.

Assessment of Patterns of Potentially Unsafe Use of Zolpidem.

Moore TJ, Mattison DR.

JAMA Intern Med. 2018 Sep 1;178(9):1275-1277. doi: 10.1001/jamainternmed.2018.3031. No abstract available.

5.

Thiazolidinedione drugs in the treatment of type 2 diabetes mellitus: past, present and future.

Davidson MA, Mattison DR, Azoulay L, Krewski D.

Crit Rev Toxicol. 2018 Jan;48(1):52-108. doi: 10.1080/10408444.2017.1351420. Epub 2017 Aug 17. Review.

PMID:
28816105
6.

External validation and comparison of two variants of the Elixhauser comorbidity measures for all-cause mortality.

Fortin Y, Crispo JA, Cohen D, McNair DS, Mattison DR, Krewski D.

PLoS One. 2017 Mar 28;12(3):e0174379. doi: 10.1371/journal.pone.0174379. eCollection 2017.

7.

The application of PBPK models in estimating human brain tissue manganese concentrations.

Ramoju SP, Mattison DR, Milton B, McGough D, Shilnikova N, Clewell HJ, Yoon M, Taylor MD, Krewski D, Andersen ME.

Neurotoxicology. 2017 Jan;58:226-237. doi: 10.1016/j.neuro.2016.12.001. Epub 2016 Dec 15.

PMID:
27989617
8.

Adult Utilization of Psychiatric Drugs and Differences by Sex, Age, and Race.

Moore TJ, Mattison DR.

JAMA Intern Med. 2017 Feb 1;177(2):274-275. doi: 10.1001/jamainternmed.2016.7507. No abstract available. Erratum in: JAMA Intern Med. 2017 Mar 1;177(3):449.

PMID:
27942726
9.

Demonstration of early efficacy results of the delayed-release combination of doxylamine-pyridoxine for the treatment of nausea and vomiting of pregnancy.

Koren G, Clark S, Hankins GD, Caritis SN, Umans JG, Miodovnik M, Mattison DR, Matok I.

BMC Pregnancy Childbirth. 2016 Nov 24;16(1):371.

10.

Manganese showcase symposium.

Mattison DR, Levy L, McGough D.

Neurotoxicology. 2017 Jan;58:171-172. doi: 10.1016/j.neuro.2016.11.004. Epub 2016 Nov 21. No abstract available.

PMID:
27880872
11.

Modeling U-shaped dose-response curves for manganese using categorical regression.

Milton B, Krewski D, Mattison DR, Karyakina NA, Ramoju S, Shilnikova N, Birkett N, Farrell PJ, McGough D.

Neurotoxicology. 2017 Jan;58:217-225. doi: 10.1016/j.neuro.2016.10.001. Epub 2016 Oct 5. Review.

PMID:
27720796
12.

Severity scoring of manganese health effects for categorical regression.

Mattison DR, Milton B, Krewski D, Levy L, Dorman DC, Aggett PJ, Roels HA, Andersen ME, Karyakina NA, Shilnikova N, Ramoju S, McGough D.

Neurotoxicology. 2017 Jan;58:203-216. doi: 10.1016/j.neuro.2016.09.001. Epub 2016 Sep 13. Review.

13.

Associations between Anticholinergic Burden and Adverse Health Outcomes in Parkinson Disease.

Crispo JA, Willis AW, Thibault DP, Fortin Y, Hays HD, McNair DS, Bjerre LM, Kohen DE, Perez-Lloret S, Mattison DR, Krewski D.

PLoS One. 2016 Mar 3;11(3):e0150621. doi: 10.1371/journal.pone.0150621. eCollection 2016.

14.

Completeness of serious adverse drug event reports received by the US Food and Drug Administration in 2014.

Moore TJ, Furberg CD, Mattison DR, Cohen MR.

Pharmacoepidemiol Drug Saf. 2016 Jun;25(6):713-8. doi: 10.1002/pds.3979. Epub 2016 Feb 10.

PMID:
26861066
15.

Effectiveness of doxylamine-pyridoxine for morning sickness.

Koren G, Hankins GD, Clark S, Caritis SN, Miodovnik M, Umans JG, Mattison DR.

Am J Obstet Gynecol. 2016 May;214(5):664-6. doi: 10.1016/j.ajog.2016.01.186. Epub 2016 Feb 1. No abstract available.

PMID:
26844757
16.

Improving Concordance in Environmental Epidemiology: A Three-Part Proposal.

LaKind JS, Goodman M, Makris SL, Mattison DR.

J Toxicol Environ Health B Crit Rev. 2015;18(2):105-20. doi: 10.1080/10937404.2015.1051612.

17.

Off-label use of cancer therapies in women diagnosed with breast cancer in the United States.

Hamel S, McNair DS, Birkett NJ, Mattison DR, Krantis A, Krewski D.

Springerplus. 2015 May 1;4:209. doi: 10.1186/s40064-015-0981-z. eCollection 2015.

18.

Maternal safety of the delayed-release doxylamine and pyridoxine combination for nausea and vomiting of pregnancy; a randomized placebo controlled trial.

Koren G, Clark S, Hankins GD, Caritis SN, Umans JG, Miodovnik M, Mattison DR, Matok I.

BMC Pregnancy Childbirth. 2015 Mar 18;15:59. doi: 10.1186/s12884-015-0488-1.

19.

Reports of pathological gambling, hypersexuality, and compulsive shopping associated with dopamine receptor agonist drugs.

Moore TJ, Glenmullen J, Mattison DR.

JAMA Intern Med. 2014 Dec;174(12):1930-3. doi: 10.1001/jamainternmed.2014.5262.

PMID:
25329919
20.

Development of a physiologically based model to describe the pharmacokinetics of methylphenidate in juvenile and adult humans and nonhuman primates.

Yang X, Morris SM, Gearhart JM, Ruark CD, Paule MG, Slikker W Jr, Mattison DR, Vitiello B, Twaddle NC, Doerge DR, Young JF, Fisher JW.

PLoS One. 2014 Sep 3;9(9):e106101. doi: 10.1371/journal.pone.0106101. eCollection 2014.

21.

Pharmaco- and toxicokinetics of selected exogenous and endogenous estrogens: a review of the data and identification of knowledge gaps.

Mattison DR, Karyakina N, Goodman M, LaKind JS.

Crit Rev Toxicol. 2014 Sep;44(8):696-724. doi: 10.3109/10408444.2014.930813. Epub 2014 Aug 6. Review.

PMID:
25099693
22.

Dabigatran, bleeding, and the regulators.

Moore TJ, Cohen MR, Mattison DR.

BMJ. 2014 Jul 23;349:g4517. doi: 10.1136/bmj.g4517. No abstract available.

PMID:
25056265
23.

Studying the antiemetic effect of vitamin B6 for morning sickness: pyridoxine and pyridoxal are prodrugs.

Matok I, Clark S, Caritis S, Miodovnik M, Umans JG, Hankins G, Mattison DR, Koren G.

J Clin Pharmacol. 2014 Dec;54(12):1429-33. doi: 10.1002/jcph.369. Epub 2014 Aug 7.

PMID:
25052410
24.

Relationships of chemical concentrations in maternal and cord blood: a review of available data.

Aylward LL, Hays SM, Kirman CR, Marchitti SA, Kenneke JF, English C, Mattison DR, Becker RA.

J Toxicol Environ Health B Crit Rev. 2014;17(3):175-203. doi: 10.1080/10937404.2014.884956. Review.

PMID:
24749481
25.

Cancer cluster investigations: review of the past and proposals for the future.

Goodman M, LaKind JS, Fagliano JA, Lash TL, Wiemels JL, Winn DM, Patel C, Van Eenwyk J, Kohler BA, Schisterman EF, Albert P, Mattison DR.

Int J Environ Res Public Health. 2014 Jan 28;11(2):1479-99. doi: 10.3390/ijerph110201479. Review.

26.

Do phthalates act as obesogens in humans? A systematic review of the epidemiological literature.

Goodman M, Lakind JS, Mattison DR.

Crit Rev Toxicol. 2014 Feb;44(2):151-75. doi: 10.3109/10408444.2013.860076. Epub 2014 Jan 14. Review.

PMID:
24417397
27.

Bisphenol A and indicators of obesity, glucose metabolism/type 2 diabetes and cardiovascular disease: a systematic review of epidemiologic research.

Lakind JS, Goodman M, Mattison DR.

Crit Rev Toxicol. 2014 Feb;44(2):121-50. doi: 10.3109/10408444.2013.860075. Epub 2014 Jan 6. Review.

PMID:
24392816
28.

Characteristics of women with nausea and vomiting of pregnancy who chose to continue compassionate use of placebo after a randomised trial.

Matok I, Umans J, Feghali MN, Clark S, Caritis S, Miodovnik M, Hankins G, Mattison DR, Nordeng H, Koren G.

J Obstet Gynaecol. 2013 Aug;33(6):557-60. doi: 10.3109/01443615.2013.774327.

PMID:
23919849
29.

A tale of two citizens: a State Attorney General and a hematologist facilitate translation of research into US Food and Drug Administration actions--a SONAR report.

Chen B, Restaino J, Norris L, Xirasagar S, Qureshi ZP, McKoy JM, Lopez IS, Trenery A, Murday A, Kahn A, Mattison DR, Ray P, Sartor O, Bennett CL.

J Oncol Pract. 2012 Nov;8(6):e158-67. doi: 10.1200/JOP.2011.000504. Epub 2012 Aug 14.

30.

The influence of sporadic anovulation on hormone levels in ovulatory cycles.

Hambridge HL, Mumford SL, Mattison DR, Ye A, Pollack AZ, Bloom MS, Mendola P, Lynch KL, Wactawski-Wende J, Schisterman EF.

Hum Reprod. 2013 Jun;28(6):1687-94. doi: 10.1093/humrep/det090. Epub 2013 Apr 15.

31.

Serum uric acid in relation to endogenous reproductive hormones during the menstrual cycle: findings from the BioCycle study.

Mumford SL, Dasharathy SS, Pollack AZ, Perkins NJ, Mattison DR, Cole SR, Wactawski-Wende J, Schisterman EF.

Hum Reprod. 2013 Jul;28(7):1853-62. doi: 10.1093/humrep/det085. Epub 2013 Apr 5.

32.

Hepatobiliary disposition of 17-OHPC and taurocholate in fetal human hepatocytes: a comparison with adult human hepatocytes.

Sharma S, Ellis EC, Gramignoli R, Dorko K, Tahan V, Hansel M, Mattison DR, Caritis SN, Hines RN, Venkataramanan R, Strom SC.

Drug Metab Dispos. 2013 Feb;41(2):296-304. doi: 10.1124/dmd.112.044891. Epub 2012 Nov 5.

33.

Bone mineral density and blood metals in premenopausal women.

Pollack AZ, Mumford SL, Wactawski-Wende J, Yeung E, Mendola P, Mattison DR, Schisterman EF.

Environ Res. 2013 Jan;120:76-81. doi: 10.1016/j.envres.2012.06.001. Epub 2012 Nov 2.

34.

The utility of menstrual cycle length as an indicator of cumulative hormonal exposure.

Mumford SL, Steiner AZ, Pollack AZ, Perkins NJ, Filiberto AC, Albert PS, Mattison DR, Wactawski-Wende J, Schisterman EF.

J Clin Endocrinol Metab. 2012 Oct;97(10):E1871-9. doi: 10.1210/jc.2012-1350. Epub 2012 Jul 26.

35.

Linking drugs to obscure illnesses: lessons from pure red cell aplasia, nephrogenic systemic fibrosis, and Reye's syndrome. a report from the Southern Network on Adverse Reactions (SONAR).

Bennett CL, Starko KM, Thomsen HS, Cowper S, Sartor O, Macdougall IC, Qureshi ZP, Bookstaver PB, Miller AD, Norris LB, Xirasagar S, Trenery A, Lopez I, Kahn A, Murday A, Luminari S, Cournoyer D, Locatelli F, Ray P, Mattison DR.

J Gen Intern Med. 2012 Dec;27(12):1697-703. doi: 10.1007/s11606-012-2098-1. Epub 2012 Jun 13. Review.

36.

The status of pharmacometrics in pregnancy: highlights from the 3(rd) American conference on pharmacometrics.

van Hasselt JG, Andrew MA, Hebert MF, Tarning J, Vicini P, Mattison DR.

Br J Clin Pharmacol. 2012 Dec;74(6):932-9. doi: 10.1111/j.1365-2125.2012.04280.x. Review.

37.

Menstrual bleeding patterns among regularly menstruating women.

Dasharathy SS, Mumford SL, Pollack AZ, Perkins NJ, Mattison DR, Wactawski-Wende J, Schisterman EF.

Am J Epidemiol. 2012 Mar 15;175(6):536-45. doi: 10.1093/aje/kwr356. Epub 2012 Feb 20.

38.

The genetic toxicity of methylphenidate: a review of the current literature.

Morris SM, Petibone DM, Lin WJ, Chen JJ, Vitiello B, Witt KL, Mattison DR.

J Appl Toxicol. 2012 Oct;32(10):756-64. doi: 10.1002/jat.2721. Epub 2012 Feb 15. Review.

PMID:
22337063
39.

Pubertal delay in male nonhuman primates (Macaca mulatta) treated with methylphenidate.

Mattison DR, Plant TM, Lin HM, Chen HC, Chen JJ, Twaddle NC, Doerge D, Slikker W Jr, Patton RE, Hotchkiss CE, Callicott RJ, Schrader SM, Turner TW, Kesner JS, Vitiello B, Petibone DM, Morris SM.

Proc Natl Acad Sci U S A. 2011 Sep 27;108(39):16301-6. doi: 10.1073/pnas.1102187108. Epub 2011 Sep 19.

40.

Using systematic reviews and meta-analyses to support regulatory decision making for neurotoxicants: lessons learned from a case study of PCBs.

Goodman M, Squibb K, Youngstrom E, Anthony LG, Kenworthy L, Lipkin PH, Mattison DR, LaKind JS.

Cien Saude Colet. 2011 Jul;16(7):3207-20. Review.

41.

Clinical therapeutics in pregnancy.

Feghali MN, Mattison DR.

J Biomed Biotechnol. 2011;2011:783528. doi: 10.1155/2011/783528. Epub 2011 Jul 6.

42.

Pharmacokinetics of oseltamivir among pregnant and nonpregnant women.

Beigi RH, Han K, Venkataramanan R, Hankins GD, Clark S, Hebert MF, Easterling T, Zajicek A, Ren Z, Mattison DR, Caritis SN; Obstetric-Fetal Pharmacology Research Units Network.

Am J Obstet Gynecol. 2011 Jun;204(6 Suppl 1):S84-8. doi: 10.1016/j.ajog.2011.03.002. Epub 2011 Mar 9.

43.

Drugs and medicines in pregnancy: the placental disposition of opioids.

Malek A, Mattison DR.

Curr Pharm Biotechnol. 2011 May;12(5):797-803. Review.

PMID:
21480827
44.

Sex differences in drug disposition.

Soldin OP, Chung SH, Mattison DR.

J Biomed Biotechnol. 2011;2011:187103. doi: 10.1155/2011/187103. Epub 2011 Feb 23. Review.

45.

A proposal to facilitate weight-of-evidence assessments: Harmonization of Neurodevelopmental Environmental Epidemiology Studies (HONEES).

Youngstrom E, Kenworthy L, Lipkin PH, Goodman M, Squibb K, Mattison DR, Anthony LG, Makris SL, Bale AS, Raffaele KC, LaKind JS.

Neurotoxicol Teratol. 2011 May-Jun;33(3):354-9. doi: 10.1016/j.ntt.2011.01.004. Epub 2011 Feb 18.

46.

Research on cytogenetic risk of ADHD treatments in children.

Mattison DR.

J Atten Disord. 2010 Nov;14(3):203-4. doi: 10.1177/1087054710381477. No abstract available.

PMID:
20978275
47.

Effectiveness of delayed-release doxylamine and pyridoxine for nausea and vomiting of pregnancy: a randomized placebo controlled trial.

Koren G, Clark S, Hankins GD, Caritis SN, Miodovnik M, Umans JG, Mattison DR.

Am J Obstet Gynecol. 2010 Dec;203(6):571.e1-7. doi: 10.1016/j.ajog.2010.07.030. Epub 2010 Sep 16.

PMID:
20843504
48.

Hurricane Katrina experience and the risk of post-traumatic stress disorder and depression among pregnant women.

Xiong X, Harville EW, Mattison DR, Elkind-Hirsch K, Pridjian G, Buekens P.

Am J Disaster Med. 2010 May-Jun;5(3):181-7. Erratum in: Am J Disaster Med. 2010 Nov-Dec;5(6):360.

49.

Environmental exposures and development.

Mattison DR.

Curr Opin Pediatr. 2010 Apr;22(2):208-18. doi: 10.1097/MOP.0b013e32833779bf. Review.

50.

Advancing the selection of neurodevelopmental measures in epidemiological studies of environmental chemical exposure and health effects.

Youngstrom E, LaKind JS, Kenworthy L, Lipkin PH, Goodman M, Squibb K, Mattison DR, Anthony BJ, Anthony LG.

Int J Environ Res Public Health. 2010 Jan;7(1):229-68. doi: 10.3390/ijerph7010229. Epub 2010 Jan 19.

Supplemental Content

Loading ...
Support Center